BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28017799)

  • 1. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
    Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
    Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
    Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
    Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
    Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
    Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
    Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.
    Herzfeld T; Nolte D; Grznarova M; Hofmann A; Schultze JL; Müller U
    Hum Mol Genet; 2013 Mar; 22(5):941-51. PubMed ID: 23184149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered glutamate response and calcium dynamics in iPSC-derived striatal neurons from XDP patients.
    Capetian P; Stanslowsky N; Bernhardi E; Grütz K; Domingo A; Brüggemann N; Naujock M; Seibler P; Klein C; Wegner F
    Exp Neurol; 2018 Oct; 308():47-58. PubMed ID: 29944858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dissection and anatomical basis of dystonia: X-linked recessive dystonia-parkinsonism (DYT3).
    Kaji R; Goto S; Tamiya G; Ando S; Makino S; Lee LV
    J Med Invest; 2005 Nov; 52 Suppl():280-3. PubMed ID: 16366515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.
    Makino S; Kaji R; Ando S; Tomizawa M; Yasuno K; Goto S; Matsumoto S; Tabuena MD; Maranon E; Dantes M; Lee LV; Ogasawara K; Tooyama I; Akatsu H; Nishimura M; Tamiya G
    Am J Hum Genet; 2007 Mar; 80(3):393-406. PubMed ID: 17273961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Glucocorticoids on
    Cruz SED; Bagamasbad P
    J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.
    Pozojevic J; Algodon SM; Cruz JN; Trinh J; Brüggemann N; Laß J; Grütz K; Schaake S; Tse R; Yumiceba V; Kruse N; Schulz K; Sreenivasan VKA; Rosales RL; Jamora RDG; Diesta CCE; Matschke J; Glatzel M; Seibler P; Händler K; Rakovic A; Kirchner H; Spielmann M; Kaiser FJ; Klein C; Westenberger A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
    Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular and anatomical bases of dystonia: X-linked recessive dystonia-parkinsonism (DYT3)].
    Kaji R; Goto S; Tamiya G; Lee LV
    Rinsho Shinkeigaku; 2005 Nov; 45(11):811-4. PubMed ID: 16447732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
    Chin HL; Lin CY; Chou OH
    Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    Petrozziello T; Dios AM; Mueller KA; Vaine CA; Hendriks WT; Glajch KE; Mills AN; Mangkalaphiban K; Penney EB; Ito N; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña G; Sharma N; Ozelius LJ; Bragg DC; Sadri-Vakili G
    PLoS One; 2020; 15(12):e0243655. PubMed ID: 33315879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding XDP through imaging, pathology, and genetics.
    Pasco PM; Ison CV; Muňoz EL; Magpusao NS; Cheng AE; Tan KT; Lo RW; Teleg RA; Dantes MB; Borres R; Maranon E; Demaisip C; Reyes MV; Lee LV
    Int J Neurosci; 2011; 121 Suppl 1():12-7. PubMed ID: 21034368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag").
    Lee LV; Rivera C; Teleg RA; Dantes MB; Pasco PM; Jamora RD; Arancillo J; Villareal-Jordan RF; Rosales RL; Demaisip C; Maranon E; Peralta O; Borres R; Tolentino C; Monding MJ; Sarcia S
    Int J Neurosci; 2011; 121 Suppl 1():3-11. PubMed ID: 21047175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and molecular analyses of X-linked dystonia-parkinsonism ("lubag") in women.
    Evidente VG; Nolte D; Niemann S; Advincula J; Mayo MC; Natividad FF; Müller U
    Arch Neurol; 2004 Dec; 61(12):1956-9. PubMed ID: 15596620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.